BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6600161)

  • 21. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of immune complexes in serum of dogs with neoplastic disease by solid-phase C1q binding, using an enzyme-linked immunosorbent assay.
    DeBoer DJ; Madewell BR
    Am J Vet Res; 1983 Sep; 44(9):1710-3. PubMed ID: 6605101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of circulating immune complexes in chronic lung diseases.
    Cooper KM; Moore M
    J Clin Lab Immunol; 1982 Apr; 7(3):155-61. PubMed ID: 6980284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune complex-like activity associated with abnormal serum lipoproteins in systemic erythematosus.
    Smith GW; Hannan SF; Scott PJ; Simpson IJ
    Clin Exp Immunol; 1982 Apr; 48(1):8-16. PubMed ID: 6979451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating immune complexes in patients with IgA glomerulonephritis.
    Nagy J; Füst G; Ambrus M; Trinn C; Paál M; Burger T
    Acta Med Acad Sci Hung; 1982; 39(3-4):211-8. PubMed ID: 6985242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.
    Mellado B; Gutierrez L; Castel T; Colomer D; Fontanillas M; Castro J; Estapé J
    Clin Cancer Res; 1999 Jul; 5(7):1843-8. PubMed ID: 10430090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immune complexes in the serum of patients with acute myeloblastic leukemia].
    Späth P; Berchtold P; Engler H; Bütler R
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1373-5. PubMed ID: 6593823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.
    Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA
    Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial measurement of circulating immune complexes in the sera of patients with leukaemia.
    Mód A; Carpentier N; Füst G; Lambert PH; Miescher P; Hollán SR
    J Clin Lab Immunol; 1980 Jul; 4(1):15-20. PubMed ID: 7007648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of immune complex by C1q solid phase enzyme immunoassay].
    Sakaeda H; Igata H; Mibuchi Y; Yonemasu K
    Rinsho Byori; 1991 Oct; 39(10):1098-104. PubMed ID: 1762185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
    Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
    J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Circulating immune complexes in a population of subjects seropositive for rheumatoid factor].
    Aureli G; Battista V; Bianchi L; Bolzonetti A; Cipriani A; Carnevali GF; Caschera F; Caputo B; Danieli G; Corvetta A
    Boll Ist Sieroter Milan; 1982; 61(5):367-74. PubMed ID: 6985415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between circulating immune complexes and renal disease in New Zealand mice.
    Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
    Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The detection of complement binding immune complexes by means of 51Cr-labelled indicator cells.
    Varga A; Kasper M; Stosiek P
    Allerg Immunol (Leipz); 1986; 32(3):205-14. PubMed ID: 2947445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The detection of circulating immune complexes in normal subjects using four different methods.
    Di Mario U; Guy K; Irvine WJ
    J Clin Lab Immunol; 1981 Mar; 5(2):95-9. PubMed ID: 6971334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.